The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
Age range
0 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Gene sequencing
Timeframe: Recurrence free survival at 2 years
Gene expression analysis
Timeframe: Recurrence free survival at 2 years
Status of genome-wide chromatin accessibility
Timeframe: Duration of active chemotherapy to two years after surgical treatment
Epigenetic change
Timeframe: Duration of active chemotherapy to two years after surgical treatment
Tumor infiltrating cells which express immune checkpoints
Timeframe: Duration of active chemotherapy to two years after surgical treatment